Precision BioSciences, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 7.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 205.36M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
Details
| Name | Precision BioSciences, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 67 |
| Founded | 2006 |
| Ipo Date | 2019-03-28 |
| Ceo | Michael Amoroso |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 16.00 |
| Isin | US74019P2074 |
| Cusip | 74019P207 |
| Cik | 1357874 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Michael Amoroso | President, Chief Executive Officer and Director |
| John Alexander Kelly R.Ph. | Chief Operating Officer |
| Dario Scimeca J.D. | Chief Legal Officer and Secretary |
| Dr. Jefferson J. Smith Ph.D. | Co-Founder and Chief Research Officer |
| Naresh Tanna | Chief Financial Officer |
| Mei Burris | Vice President of Finance and Chief Accounting Officer |
| Dr. Cassie Gorsuch Ph.D. | Chief Scientific Officer |
| Juli Blanche | Chief People Officer |
| Cindy Atwell | Chief Development Officer |
| Neil Leatherbury M.S. | Senior Vice President and Head of Chemistry, Manufacturing and Controls |
Contact
| Address | 302 East Pettigrew St., Suite A-100, Durham, North Carolina 27701, United States |
| Phone | 919 314 5512 |
| Website | https://precisionbiosciences.com |